Research programme: ion trap technology based therapeutics - ZS Pharma

Drug Profile

Research programme: ion trap technology based therapeutics - ZS Pharma

Alternative Names: Non absorbed binders - ZS Pharma

Latest Information Update: 24 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ZS Pharma
  • Class Minerals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Cardiovascular disorders; Kidney disorders; Liver disorders; Metabolic disorders

Most Recent Events

  • 17 Dec 2015 ZS Pharma has been acquired by AstraZeneca
  • 14 Aug 2014 Early research in Cardiovascular disorders in USA (unspecified route)
  • 14 Aug 2014 Early research in Kidney disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top